Salon Grafix has announced the relaunch of the cult-favorite Professional hair spray.
Prestige lip color sales in the United States experienced a 24% increase in dollar sales during the month of November as the bold lip trend shows little signs of fading, according to global information company, The NPD Group.
Twelve holiday health hazards, provided by Vitals.
Estée Lauder has signed an agreement to acquire Glamglow, a skin care brand focused on treatment masks. Terms of the deal were not disclosed. The acquisition is expected to close in January 2015.
The Food and Drug Administration has approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections and complicated urinary tract infections.
The Food and Drug Administration has approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.
Sandoz has announced the U.S. market introduction of estradiol transdermal system, an authorized generic version of Vivelle-Dot, which is marketed by Novartis Pharmaceuticals.
Mylan has announced the U.S. launch of its Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day (twice weekly), which is the generic version of Novartis' Vivelle-DOT.
AB Acquisition LLC (Albertsons) and Safeway have entered into agreements to sell 168 stores across eight states to four buyers — Associated Food Stores, Associated Wholesale Grocers, Supervalu and Haggen.
Walgreens on Friday announced that it intends to apply to list the shares of Walgreens Boots Alliance common stock on The Nasdaq Stock Market under the ticker symbol “WBA” following the closing of the previously announced reorganization of Walgreens into a holding company structure.